If guidance is achieved as seems likely($36-40M) for F'24 and with larger scale clinical studies to report throughout the year and beyond, the excellent sales team IV has assembled, the potential of this unique technology which is applicable across a broad spectrum of healthcare (TAM $12Billion) the potential of Next Science is unlimited.
Only wish I had more funds to invest....
Ann: Next Science reports FY23 Result, page-10
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
-0.020(7.55%) |
Mkt cap ! $71.46M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 26.0¢ | 24.5¢ | $48.55K | 190.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.5¢ | 2488 | 1 |
View Market Depth
| Last trade - 15.55pm 19/06/2024 (20 minute delay) ? |
| NXS (ASX) Chart |